1.Role of HSP70 Expression in the Development of Endometrial Adenocarcinoma Correlation of ER, PR, p53, and bcl-2 protein expressions and apoptosis .
Mi Seon KANG ; Seo Young PARK ; Sang Bo LEE ; Hye Kyoung YOON
Korean Journal of Pathology 2000;34(5):358-365
Heat shock protein of 72 kDa (HSP70) has a role in the functional modulation of sex steroid hormone receptors and in p53-associated oncogenesis and inhibits apoptosis associated with bcl-2. However, the exact role of HSP70 in the development of endometrial adenocarcinoma has not been well established. The aim of this study is to evaluate the role of HSP70 in relation with ER, PR, p53 and bcl-2 expressions and apoptosis in benign and malignant endometrial lesions. Immunohistochemical studies for HSP70, ER, PR, p53, bcl-2 and TUNEL method for apoptosis were performed in 30 cases of adenocarcinoma and 30 cases of benign endometrial lesions consisted of each 10 cases of disordered proliferative endometrium (DP), simple or complex hyperplasia (HP), and atypical hyperplasia (AH). There were no significant differences of HSP70 and bcl-2 expression rates and apoptotic index (AI) between DP, HP, AH, and adenocarcinoma. p53 expression rate in adenocarcinoma was 36.7%, but no p53 expression was identified in DP, HP and AH (p<0.05). In adenocarcinoma, HSP70 expression rate was higher in ER and PR negative adenocarcinoma (p<0.05), and p53 expression rate was higher in nonendometrioid type and FIGO grade II and III (p<0.05), but no significant difference of bcl-2 expression rate according to the histological type and FIGO grade. AI was higher in nonendometrioid type (p<0.05). There was no correlation between HSP70, p53 and bcl-2 expressions, and no significant difference of AI according to HSP70, ER, PR, p53, and bcl-2 expressions. In conclusion, higher HSP70 expression rate in poorly differentiated and ER and PR negative adenocarcinoma suggests that HSP70 inhibits ER and PR expression and may be involved in the development of poorly differentiated endometrial adenocarcinoma.
Adenocarcinoma*
;
Apoptosis*
;
Carcinogenesis
;
Endometrium
;
Female
;
Heat-Shock Proteins
;
Hyperplasia
;
In Situ Nick-End Labeling
2.Erratum: Late Preterm Infants' Outcome Born from Mothers with Positive Screening but Negative Diagnostic Test for Gestational Diabetes.
Jeong Min LEE ; Bo Seon SEO ; Eun Sun KIM
Korean Journal of Perinatology 2015;26(4):377-377
We would like to correct the author affiliations.
3.Late Preterm Infants' Outcome Born from Mothers with Positive Screening but Negative Diagnostic Test for Gestational Diabetes.
Jeong Min LEE ; Bo Seon SEO ; Eun Sun KIM
Korean Journal of Perinatology 2015;26(3):200-207
PURPOSE: The aim of the study is to determine whether late preterm infants from normal oral GTT (glucose tolerance test) but positive GCT (glucose challenge test) mothers are associated with adverse postnatal outcome. METHODS: A retrospective study was performed from singleton infants who were born at 34(+0)-36(+6) weeks between January 2008 and December 2012 and prenatally checked at CHA Gangnam Medical Center. Infants were categorized into three groups according to the results of 50 g oral GCT and 100 g oral GTT; NG group (normal glucose tolerance group, n=603) vs. GIG group (gestational impaired glucose tolerance group; infants of normal oral GTT but positive GCT mothers, n=77) vs. GDM group (gestational diabetes group, n=52). Neonatal outcomes were compared among the three groups. RESULTS: GIG group showed significantly increased incidence of jaundice compared to NG group (9.6% vs. 19.5%, P=0.031). The number of old mothers (> or =35 years at delivery) was significantly higher in GIG group compared to NG group (27.5% vs. 33.8%, P=0.006). After stratification by maternal age, GIG group showed significantly increased respiratory diseases compared to NG group (44% vs. 65.4%, P=0.04). Hypocalcemia and feeding problem increased across the groups (NG vs. GIG vs. GDM; 13.3% vs. 26.9% vs. 32.0%, P= 0.024; 6.0% vs. 11.5% vs. 20.0%, P=0.05, respectively). CONCLUSION: Late preterm infants of normal oral GTT but positive GCT mothers, especially in older mother, have increased risk of postnatal morbidities such as respiratory distress, jaundice, hypocalcemia or feeding intolerance. Thus, careful follow up may be needed in this group since antepartum period.
Diabetes, Gestational*
;
Diagnostic Tests, Routine*
;
Female
;
Follow-Up Studies
;
Glucose
;
Glucose Intolerance
;
Humans
;
Hypocalcemia
;
Incidence
;
Infant
;
Infant, Newborn
;
Infant, Premature
;
Jaundice
;
Mass Screening*
;
Maternal Age
;
Mothers*
;
Pregnancy
;
Retrospective Studies
4.Two Cases of Primary Malignant Mixed Mullerian Tumor of the ovary.
Ji Eun LEE ; Seo Yun TONG ; Seon Kyung LEE ; Seung Bo KIM ; Hui Ju LEE
Korean Journal of Obstetrics and Gynecology 2005;48(8):1897-1904
Malignant mixed mullerian tumor of the ovary are very aggressive tumors that were usually diagnosed at an older age. They are usually at an advanced stage at the time of diagnosis, and survival after diagnosis varies by stage of disease and histological type. Despite aggressive treatment that includes surgery and chemotherapy, women with these tumors have a significantly increased risk of death giving them a very poor prognosis. The poor prognosis associated with this rare disease represents a need to new therapeutic regimens to improve patients' survival. We experienced two cases of primary malignant mixed mullerian tumor of the ovary.
Diagnosis
;
Drug Therapy
;
Female
;
Humans
;
Ovary*
;
Prognosis
;
Rare Diseases
5.Two Cases of Primary Malignant Mixed Mullerian Tumor of the ovary.
Ji Eun LEE ; Seo Yun TONG ; Seon Kyung LEE ; Seung Bo KIM ; Hui Ju LEE
Korean Journal of Obstetrics and Gynecology 2005;48(8):1988-1994
Malignant mixed mullerian tumor of the ovary are very aggressive tumors that were usually diagnosed at an older age. They are usually at an advanced stage at the time of diagnosis, and survival after diagnosis varies by stage of disease and histological type. Despite aggressive treatment that includes surgery and chemotherapy, women with these tumors have a significantly increased risk of death giving them a very poor prognosis. The poor prognosis associated with this rare disease represents a need to new therapeutic regimens to improve patients' survival. We experienced two cases of primary malignant mixed mullerian tumor of the ovary.
Diagnosis
;
Drug Therapy
;
Female
;
Humans
;
Ovary*
;
Prognosis
;
Rare Diseases
6.A 22-month-old Boy with Acute Glomerulonephritis Coexistent with Hemolytic Anemia and Idiopathic Thrombocytopenia.
Hye Won PARK ; Bo Seon SEO ; Su Jin JUNG ; Jun Ho LEE
Childhood Kidney Diseases 2015;19(1):43-47
Hemolytic anemia and thrombocytopenia are rare clinical manifestations of acute glomerulonephritis. Initially, in all such cases, a diagnosis of hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, systemic lupus erythematosus, and amyloidosis should be ruled out. The presence of hemolytic anemia and thrombocytopenia is rare, but possible, in a case of acute poststreptococcal glomerulonephritis, and may result in delayed diagnosis or misdiagnosis. Correct and timely diagnosis would ensure adequate treatment in such patients. We report of a 22-month-old boy with acute glomerulonephritis coexistent with hemolytic anemia and idiopathic thrombocytopenia.
Amyloidosis
;
Anemia, Hemolytic*
;
Delayed Diagnosis
;
Diagnosis
;
Diagnostic Errors
;
Glomerulonephritis*
;
Hemolytic-Uremic Syndrome
;
Humans
;
Infant*
;
Lupus Erythematosus, Systemic
;
Male
;
Purpura, Thrombotic Thrombocytopenic
;
Thrombocytopenia*
7.A 22-month-old Boy with Acute Glomerulonephritis Coexistent with Hemolytic Anemia and Idiopathic Thrombocytopenia.
Hye Won PARK ; Bo Seon SEO ; Su Jin JUNG ; Jun Ho LEE
Childhood Kidney Diseases 2015;19(1):43-47
Hemolytic anemia and thrombocytopenia are rare clinical manifestations of acute glomerulonephritis. Initially, in all such cases, a diagnosis of hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, systemic lupus erythematosus, and amyloidosis should be ruled out. The presence of hemolytic anemia and thrombocytopenia is rare, but possible, in a case of acute poststreptococcal glomerulonephritis, and may result in delayed diagnosis or misdiagnosis. Correct and timely diagnosis would ensure adequate treatment in such patients. We report of a 22-month-old boy with acute glomerulonephritis coexistent with hemolytic anemia and idiopathic thrombocytopenia.
Amyloidosis
;
Anemia, Hemolytic*
;
Delayed Diagnosis
;
Diagnosis
;
Diagnostic Errors
;
Glomerulonephritis*
;
Hemolytic-Uremic Syndrome
;
Humans
;
Infant*
;
Lupus Erythematosus, Systemic
;
Male
;
Purpura, Thrombotic Thrombocytopenic
;
Thrombocytopenia*
8.Analysis of Heart Rate Variability in Patients BPH.
Young Kyun KIM ; Jong Bo CHOI ; Kyung Sik SEO ; Yong Seon HEO ; Byung Cheol AHN ; Young Soo KIM
Journal of the Korean Continence Society 2005;9(1):17-22
PURPOSE: To characterize autonomic dysfunction in patients with benign prostatic hyperplasia(BPH), we measured heart rate variability(HRV) and analyzed them compared with those of normal population. MATERIALS AND METHODS: ECG signals were obtained from 11 male patients(mean age, 63.1 years) and 23 healthy male controls(mean age, 57.0 years) in resting state. We analyzed their parameters of HRV and compared them between groups. RESULTS: Time domain analysis including standard deviation of NN interval(SDNN), square root of mean of sum of squares of differences between adjacent NN intervals(RMSSD) in patients with BPH were not significantly different with those of controls. There were suggested evidence of decreased total power(TP), high frequency (HF) in patients with BPH(p<0.05) while no significant difference in other frequency domain such as very low frequency(VLF), low frequency(LF) and LF/HF ratio. CONCLUSION: This preliminary study shows that patients with BPH have different results on HRV study comparing to controls. With the exception of LF and LF/HF ratio, all parameters of HRV in patients with BPH lower than normal controls. TP, HF in patients with BPH significantly lower than that of normal controls. The decreased values of HRV study means that they may have some kinds of disease or imbalance in autonomic nervous system(ANS). So we suggest that HRV study may be a tool to describe the possibility of altered ANS activity in patients with BPH.
Autonomic Nervous System
;
Electrocardiography
;
Heart Rate*
;
Heart*
;
Humans
;
Male
9.Clinical Analysis of The Invasive Cervical Cancer Patients Treated by Radical Hysterectomy.
Young Joon CHOI ; Seon Kyung LEE ; Myong Cheol LIM ; Sang Gi SEO ; Seung Bo KIM
Korean Journal of Obstetrics and Gynecology 2005;48(1):88-99
OBJECTIVE: This study was undertaken to analyze the demographic profile and clinicopathologic characteristics of the patients with invasive cervical cancer who had undergone radical hysterectomy. METHODS: Records of 285 patients with invasive cervical cancer who had undergone radical hysterectomy and pelvic lymph node dissection at Kyung Hee University Hospital from January 1986 to March 2001 were reviewed retrospectively. In this study, we analyzed the clinicopathologic characteristics such as age, FIGO stage, histologic type, nodal metastasis, treatment modalities, complications, recurrence rates, and the overall 5-year survival rates et al. by using univariate anaysis and Kaplan-Meier method. RESULTS AND CONCLUSION: Ages ranged from 28 to 78. The mean age was 50.6. The number of patients of 285 being in FIGO stage Ia was 34 (11.9%), Ib 146 (51.2%), IIa 78 (27.4%), IIb 27 (9.5%). In the distribution of histological type, the number of squamous cell carcinoma was 258 (90.5%), adenocarcinoma 20 (7.0%), adenosquamous carcinoma 7 (2.5%). LN involvement was present in 5.9% with stage Ia, 16.4% with Ib, 24.4% with IIa, 25.9% with IIb. Obturator LN was the most frequently involved among pelvic lymph node. Urinary tract infection was the most common complication after surgery, occupying 15.1%. 26 cases (9.1%) developed recurrence. The recurrence rate was 0% in stage Ia, 8.2% in stage Ib, 11.5% in stage IIa, 18.5% in stage IIb. The overall 5-year survival rate was 100% in stage Ia, 89.4% in stage Ib, 80.0% in stage IIa and 72.2% in stage IIb. FIGO stage, tumor mass size, resection margin, lymph node involvement had a statistical prognostic significance (P<0.01).
Adenocarcinoma
;
Carcinoma, Adenosquamous
;
Carcinoma, Squamous Cell
;
Humans
;
Hysterectomy*
;
Lymph Node Excision
;
Lymph Nodes
;
Neoplasm Metastasis
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Urinary Tract Infections
;
Uterine Cervical Neoplasms*
10.A Pilot Study of HRV(Heart Rate Variability) in Patient with Urinary Incontinence.
Kyeong Sik SEO ; Jong Bo CHOI ; Yong Seon HEO ; Byung Chul AHN ; Seong Ryong KIM ; Young Soo KIM
Journal of the Korean Continence Society 2005;9(2):130-134
PURPOSE: To compare autonomic dysfunction in patients with urge urinary incontinence(UUI), patients with stress urinary incontinence(SUI) and normal group, we measured and analyzed heart rate variability to compare among the three groups. MATERIALS AND METHODS: We studied heart rate variability(HRV) in 30 patients with UUI(mean age, 47.7+/-10.0 years old), 40 patients with SUI(mean age, 47.6+/-8.7 years old), 120 healthy controls(mean age 45.2+/-6.9 years old). The parameters of HRV of the three groups were compared. RESULTS: There was no difference in uroflowmetry and heart rate among the three groups. In time domain, square root of the mean squared difference of successive N-N interval(RMSSD) in UUI was higher than that of the others, and standard deviation of N-N interval(SDNN) showed no difference. In frequency domain, low frequency(LF) in UUI, an indicator of cardiac sympathetic tone, was higher than thar of the others. Very low frequency(VLF), LF, low-frequency/high-frequency ratio(LF/HF ratio) didn't show difference. CONCLUSION: All parameters of HRV analysis in UUI were not same as those of SUI and controls. The increase in RMSSD and HF means that there could be imbalance in autonomic nervous system and it could be the cause of detrusor overactivity in UUI.
Autonomic Nervous System
;
Heart Rate
;
Humans
;
Pilot Projects*
;
Urinary Incontinence*